e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Asthma: growing understanding of influential factors
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The course of aspirin-induced asthma may be helpful in predicting the type of response to aspirin
M. Swierczynska, E. Nizankowska-Mogilnicka, P. Strek, A. Gielicz, M. Grzywacz, A. Szczeklik (Cracow, Poland)
Source:
Annual Congress 2008 - Asthma: growing understanding of influential factors
Session:
Asthma: growing understanding of influential factors
Session type:
Thematic Poster Session
Number:
1152
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Swierczynska, E. Nizankowska-Mogilnicka, P. Strek, A. Gielicz, M. Grzywacz, A. Szczeklik (Cracow, Poland). The course of aspirin-induced asthma may be helpful in predicting the type of response to aspirin. Eur Respir J 2008; 32: Suppl. 52, 1152
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Clinical relevance of anti-inflammatory treatment of rhinitis for the course and prognosis of allergic bronchial asthma
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009
Early treatment response may predict long-term mepolizumab benefit in severe asthma
Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies
Year: 2019
Suppression of
F
ENO
with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice?
Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019
Year: 2019
Omalizumab is effective in patients with severe persistent allergic asthma in a real-life setting irrespective of age
Source: Annual Congress 2009 - Towards improving asthma control
Year: 2009
Comparison of residual eosinophilic inflammation in the distal airway of patients with well-controlled asthma using different drug combinations of asthma treatment
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Add-on omalizumab therapy reduces clinically significant and severe asthma exacerbations, and improves FEV
1
in patients with severe persistent allergic asthma irrespective of age
Source: Eur Respir J 2005; 26: Suppl. 49, 48s
Year: 2005
Omalizumab therapy reduces oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma: European real-life experience
Source: Annual Congress 2009 - Severe asthma and its treatment
Year: 2009
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Immunological effectiveness of atorvastatin in complex therapy of severe persistent bronchial asthma
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009
Clinical features and their link with asthma exacerbations amongst aspirin-induced asthmatics
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma
Source: Annual Congress 2007 - New drugs for asthma
Year: 2007
Is antibiotic treatment during asthma exacerbation necessary ?
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Predictors of response to therapy with omalizumab in patients with severe allergic asthma–a real life study
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Basophil activation test as support for distinguishing between aspirin-induced asthma and allergic reaction to ASA
Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases
Year: 2011
The importance of early applying inhaled corticosteroids in patients with mild bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 57s
Year: 2002
Effect of asthma and asthma medication on the prognosis of patients with COVID-19
Source: Eur Respir J, 57 (3) 2002226; 10.1183/13993003.02226-2020
Year: 2021
Is omalizumab response influenced by passive smoking in severe asthma?
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Clinical and functional effectiveness of atorvastatin in complex therapy of severe bronchial asthma
Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Year: 2009
Physicians judge add-on omalizumab therapy as an effective treatment for patients with severe persistent allergic asthma: a pooled analysis
Source: Eur Respir J 2005; 26: Suppl. 49, 49s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept